1
Essers, Brigitte A. B., Seferina, Shanley C., Tjan-Heijnen, Vivianne C. G., Severens, Johan L., Novak, Annoesjka, Pompen, Marjolein, Oron, Ulrich H., Joore, Manuela A.
Veröffentlicht in: Essers , B A B , Seferina , S C , Tjan-Heijnen , V C G , Severens , J L , Novak , A , Pompen , M , Oron , U H & Joore , M A 2010 , ' Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands ' , Value in Health , vol. 13 , no. 4 , pp. 375-380 . https://doi.org/10.1111/j.1524-4733.2009.00683.x;
2010
Veröffentlicht in: Essers , B A B , Seferina , S C , Tjan-Heijnen , V C G , Severens , J L , Novak , A , Pompen , M , Oron , U H & Joore , M A 2010 , ' Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands ' , Value in Health , vol. 13 , no. 4 , pp. 375-380 . https://doi.org/10.1111/j.1524-4733.2009.00683.x;
2010
2
3
Seferina, Shanly C., Ramaekers, Bram L. T., de Boer, Maaike, Dercksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J. W., de Wouw, Agnes J. van, Voogd, Adri C., Heijnen, Vivianne C. G. Tjan, Joore, Manuela A.
Veröffentlicht in: Seferina , S C , Ramaekers , B L T , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , de Wouw , A J V , Voogd , A C , Heijnen , V C G T & Joore , M A 2017 , ' Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting : A study of the Southeast Netherlands Breast Cancer Consortium ' , Oncotarget , vol. 8 , no. 45 , pp. 79223-79233 . https://doi.org/10.18632/oncotarget.16985;
2017
Veröffentlicht in: Seferina , S C , Ramaekers , B L T , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , de Wouw , A J V , Voogd , A C , Heijnen , V C G T & Joore , M A 2017 , ' Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting : A study of the Southeast Netherlands Breast Cancer Consortium ' , Oncotarget , vol. 8 , no. 45 , pp. 79223-79233 . https://doi.org/10.18632/oncotarget.16985;
2017
4
Seferina, S.C., Lobbezoo, D.J.A., de Boer, M., Dercksen, M.W., van den Berkmortel, F., van Kampen, R.J.W., van de Wouw, A.J., de Vries, B., Joore, M.A., Peer, P.G.M., Voogd, A.C., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Seferina , S C , Lobbezoo , D J A , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , van de Wouw , A J , de Vries , B , Joore , M A , Peer , P G M , Voogd , A C & Tjan-Heijnen , V C G 2015 , ' Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium ' , Oncologist , vol. 20 , no. 8 , pp. 856-863 . https://doi.org/10.1634/theoncologist.2015-0006;
2015
Veröffentlicht in: Seferina , S C , Lobbezoo , D J A , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , van de Wouw , A J , de Vries , B , Joore , M A , Peer , P G M , Voogd , A C & Tjan-Heijnen , V C G 2015 , ' Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium ' , Oncologist , vol. 20 , no. 8 , pp. 856-863 . https://doi.org/10.1634/theoncologist.2015-0006;
2015